These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34669680)

  • 1. Topical Medication Adherence and Visual Field Progression in Open-angle Glaucoma: Analysis of a Large US Health Care System.
    Shu YH; Wu J; Luong T; Mattox C; Fang EN; Lee BL; Jones JP; Campbell J; Shih V; Zhao C; Fong DS
    J Glaucoma; 2021 Dec; 30(12):1047-1055. PubMed ID: 34669680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Medication Adherence and Visual Field Progression in the Collaborative Initial Glaucoma Treatment Study.
    Newman-Casey PA; Niziol LM; Gillespie BW; Janz NK; Lichter PR; Musch DC
    Ophthalmology; 2020 Apr; 127(4):477-483. PubMed ID: 31932093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.
    Musch DC; Gillespie BW; Lichter PR; Niziol LM; Janz NK;
    Ophthalmology; 2009 Feb; 116(2):200-7. PubMed ID: 19019444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do adherence rates and glaucomatous visual field progression correlate?
    Rossi GC; Pasinetti GM; Scudeller L; Radaelli R; Bianchi PE
    Eur J Ophthalmol; 2011; 21(4):410-4. PubMed ID: 21140373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased rate of visual field loss associated with larger initial visual field threshold values on follow-up of open-angle glaucoma.
    Schwartz B; Takamoto T; Martin J
    J Glaucoma; 2004 Apr; 13(2):120-9. PubMed ID: 15097257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline prognostic factors predict rapid visual field deterioration in glaucoma.
    Lee JM; Caprioli J; Nouri-Mahdavi K; Afifi AA; Morales E; Ramanathan M; Yu F; Coleman AL
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2228-36. PubMed ID: 24458154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of visual field progression in new-diagnosed primary open-angle and exfoliation glaucoma patients in Sweden.
    Ayala M
    BMC Ophthalmol; 2020 Aug; 20(1):322. PubMed ID: 32758192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for visual field loss progression in patients with primary open-angle glaucoma in Wenzhou area].
    Zhou K; Shang X; Wang XY; Wang XJ; Cheng HH; Hu HS; Huang QJ; Pan XF; Xu X; Liang YB
    Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):777-784. PubMed ID: 31607067
    [No Abstract]   [Full Text] [Related]  

  • 10. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma.
    Kwon YH; Kim CS; Zimmerman MB; Alward WL; Hayreh SS
    Am J Ophthalmol; 2001 Jul; 132(1):47-56. PubMed ID: 11438053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHORT TERM EVALUATION OF PERIMETRIC PROGRESSION IN PATIENTS WITH OPEN ANGLE GLAUCOMA AND DIABETES.
    Pantalon A; Feraru C; Chiseliţa D
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):83-9. PubMed ID: 27125077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH; Nicolela MT; LeBlanc RP; Chauhan BC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucomatous Visual Field Progression in the African Descent and Glaucoma Evaluation Study (ADAGES): Eleven Years of Follow-up.
    Melchior B; Valenzuela IA; De Moraes CG; Paula JS; Fazio MA; Girkin CA; Proudfoot J; Cioffi GA; Weinreb RN; Zangwill LM; Liebmann JM
    Am J Ophthalmol; 2022 Jul; 239():122-129. PubMed ID: 35172170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss.
    Bommakanti N; De Moraes CG; Boland MV; Myers JS; Wellik SR; Elze T; Pasquale LR; Shen LQ; Ritch R; Liebmann JM
    J Glaucoma; 2020 Jan; 29(1):31-38. PubMed ID: 31688371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Genetic Variant in TGFBR3-CDC7 Is Associated with Visual Field Progression in Primary Open-Angle Glaucoma Patients from Singapore.
    Trikha S; Saffari E; Nongpiur M; Baskaran M; Ho H; Li Z; Tan PY; Allen J; Khor CC; Perera SA; Cheng CY; Aung T; Vithana E
    Ophthalmology; 2015 Dec; 122(12):2416-22. PubMed ID: 26383992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals: Findings From a Median 25-Year Follow-up.
    Giammaria S; Hutchison DM; Rafuse PE; Shuba LM; LeBlanc RP; Nicolela MT; Chauhan BC
    JAMA Ophthalmol; 2022 May; 140(5):504-511. PubMed ID: 35389449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of visual field progression in clinical glaucoma care.
    Heijl A; Buchholz P; Norrgren G; Bengtsson B
    Acta Ophthalmol; 2013 Aug; 91(5):406-12. PubMed ID: 23066646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Brimonidine and Timolol on the Progression of Visual Field Defects in Open-angle Glaucoma: A Single-center Randomized Trial.
    Yokoyama Y; Kawasaki R; Takahashi H; Maekawa S; Tsuda S; Omodaka K; Nakazawa T
    J Glaucoma; 2019 Jul; 28(7):575-583. PubMed ID: 31188229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.